TGFB1 and neoplasm: Here we describe the selectivity of galunisertib for the TGFβRI kinase domain and demonstrate the ability of galunisertib to inhibit TGFβ-dependent tumor cell intrinsic and extrinsic functions using in vitro and in vivo assays, and to inhibit tumor growth in established tumor mouse models.